Genophenotypic factors and pharmacogenomics in adverse drug reactions
R Cacabelos, V Naidoo, L Corzo, N Cacabelos… - International journal of …, 2021 - mdpi.com
Adverse drug reactions (ADRs) rank as one of the top 10 leading causes of death and
illness in developed countries. ADRs show differential features depending upon genotype …
illness in developed countries. ADRs show differential features depending upon genotype …
Prevalence of polymorphisms in thiopurine metabolism and association with adverse outcomes: a South Asian region-specific systematic review and meta-analysis
Background: Prevalence and impact of thiopurine S-methyltransferase (TPMT) and Nudix
hydrolase (NUDT15) minor allele frequencies in South Asian population is unclear …
hydrolase (NUDT15) minor allele frequencies in South Asian population is unclear …
Reducing risk in thiopurine therapy
AM Marinaki, M Arenas-Hernandez - Xenobiotica, 2020 - Taylor & Francis
The thiopurine drugs azathioprine and mercaptopurine are effective in the treatment of
disorders of immune regulation and acute lymphoblastic leukaemia. Although developed in …
disorders of immune regulation and acute lymphoblastic leukaemia. Although developed in …
Implementation of pharmacogenetics to individualize treatment regimens for children with acute lymphoblastic leukemia
Despite major advances in the management and high cure rates of childhood acute
lymphoblastic leukemia (ALL), patients still suffer from many drug-induced toxicities …
lymphoblastic leukemia (ALL), patients still suffer from many drug-induced toxicities …
Pharmacogenomics in Lebanon: current status, challenges and opportunities
Pharmacogenomics (PGx) research and applications are of utmost relevance in Lebanon
considering its population genetic diversity. Moreover, as a country with regional leadership …
considering its population genetic diversity. Moreover, as a country with regional leadership …
Pharmacogenomics in pediatric oncology: mitigating adverse drug reactions while preserving efficacy
AA Elzagallaai, BC Carleton… - Annual review of …, 2021 - annualreviews.org
Cancer is the leading cause of death in American children older than 1 year of age. Major
developments in drugs such as thiopurines and optimization in clinical trial protocols for …
developments in drugs such as thiopurines and optimization in clinical trial protocols for …
Optimizing thiopurine therapy in children with acute lymphoblastic leukemia: A promising “MINT” sequencing strategy and therapeutic “DNA-TG” monitoring
HL Guo, YT Zhao, WJ Wang, N Dong, YH Hu… - Frontiers in …, 2022 - frontiersin.org
Thiopurines, including thioguanine (TG), 6-mercaptopurine (6-MP), and azathioprine (AZA),
are extensively used in clinical practice in children with acute lymphoblastic leukemia (ALL) …
are extensively used in clinical practice in children with acute lymphoblastic leukemia (ALL) …
Childhood acute lymphoblastic leukemia mercaptopurine intolerance is associated with NUDT15 variants
DS Wang, CH Yu, CY Lin, YH Chang, KH Lin… - Pediatric …, 2021 - nature.com
Background Mercaptopurine-induced neutropenia can interrupt chemotherapy and expose
patients to infection during childhood acute lymphoblastic leukemia (ALL) treatment …
patients to infection during childhood acute lymphoblastic leukemia (ALL) treatment …
Effects of TPMT, NUDT15, and ITPA Genetic Variants on 6-Mercaptopurine Toxicity for Pediatric Patients With Acute Lymphoblastic Leukemia in Yunnan of China
X Mao, R Yin, G Sun, Y Zhou, C Yang, C Fang… - Frontiers in …, 2021 - frontiersin.org
Background: 6-Mercaptopurine (6-MP) is the cornerstone of current antileukemia regimen
and contributes greatly to improve the survival of pediatric acute lymphoblastic leukemia …
and contributes greatly to improve the survival of pediatric acute lymphoblastic leukemia …
Effect of ITPA polymorphism on adverse drug reactions of 6-mercaptopurine in pediatric patients with acute lymphoblastic leukemia: a systematic review and meta …
6-Mercaptopurine (6-MP) is a cornerstone of the maintenance regimen for pediatric acute
lymphoblastic leukemia (ALL). Inosine triphosphate pyrophosphatase (ITPA) is considered a …
lymphoblastic leukemia (ALL). Inosine triphosphate pyrophosphatase (ITPA) is considered a …